Medical device maker Medtronic, Inc. (NYSE: MDT) reported year-over-year (y-o-y) operational sales growth of over 4% in the third quarter of fiscal 2014 to about $4.2 billion, driven by steady growth across all its divisions. Its largest divisions, Cardiac Rhythm Disease Management and Cardiovascular, continued to grow in the low single digits while its other divisions such as Neuromodulation, Surgical Technologies and Diabetes also registered solid growth.
Medical device maker Medtronic, Inc. (NYSE: MDT) reported year-over-year (y-o-y) operational sales growth of over 4% in the third quarter of fiscal 2014 to about $4.2 billion, driven by steady growth across all its divisions. Its largest divisions, Cardiac Rhythm Disease Management and Cardiovascular, continued to grow in the low single digits while its other divisions such as Neuromodulation, Surgical Technologies and Diabetes also registered solid growth.
Share this Article
Comment on this Article
Recommended
Please to comment